The major objective of the Tissue Procurement and Biospecimens Core Facility (TPF) is to support and enhance cancer-related translational, clinical, population and basic science research by providing UNC Lineberger Comprehensive Cancer Center members with a centralized, coordinated, quality-controlled, quality-assured facility for procurement, processing, storage, and distribution of normal and malignant human specimens. Included in these services is the processing of blood for serum, plasma, packed red blood cells, and buffy coats. In addition, the facility serves as a centralized facility for DNA extraction from whole blood and buccal swabs, in support of several large population-based epidemiologic studies, as well as clinical research studies. Additional biospecimens collected and stored by the facility, especially in support of epidemiology studies, include fat biopsies, toenails, urine, and other body fluids as defined by the research study. The Facility works with each investigator to accommodate specific needs and applications, including planning and performing experiments to optimize specimen handling. The TPF coordinates and integrates activities with several other cores, including the Translational Core, the Genomics Core, the Proteomics Core, and the High Throughput Genotyping Core, further facilitating investigators' studies. In addition to peer- reviewed investigators, the facility serves to support many pilot studies and institutionally supported studies that establish or confirm preliminary data for subsequent submission for peer-reviewed grants, especially for newly recruited clinical faculty. The core facility's activities are integrated with the efforts of the UNC LCCC Clinical Protocol Office, supporting clinical ontology trials, both institutional and national, that require specimen collection, processing, storage, and shipping. The facility is also highly integrated with the Biostatistics and Data Monitoring Core. These efforts support further translation of research from bench to bedside. The Facility has developed and implemented policies and procedures to address medical, legal and ethical issues, as well as scientific and logistic review of proposals requesting use of the Facility services. A customized database system serves to track, monitor and inventory banked specimens, integrating quality assurance and pathologic information using an honest broker model.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-33
Application #
7645550
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-12-01
Budget End
2008-11-30
Support Year
33
Fiscal Year
2008
Total Cost
$468,289
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Ma, Shaohua; Paiboonrungruan, Chorlada; Yan, Tiansheng et al. (2018) Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target. Ann N Y Acad Sci 1434:164-172
Aung, Kyaw L; Fischer, Sandra E; Denroche, Robert E et al. (2018) Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial. Clin Cancer Res 24:1344-1354
Suh, Junghyun L; Watts, Brian; Stuckey, Jacob I et al. (2018) Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1. Biochemistry 57:2140-2149
Brock, William J; Beaudoin, James J; Slizgi, Jason R et al. (2018) Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease. Int J Toxicol 37:144-154
Thomas, Nancy E; Edmiston, Sharon N; Tsai, Yihsuan S et al. (2018) Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis. Am J Dermatopathol :
Bensen, Jeannette T; Graff, Mariaelisa; Young, Kristin L et al. (2018) A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women. Breast Cancer Res 20:45
Hall, Marissa G; Marteau, Theresa M; Sunstein, Cass R et al. (2018) Public support for pictorial warnings on cigarette packs: an experimental study of US smokers. J Behav Med 41:398-405
Thorsson, Vésteinn; Gibbs, David L; Brown, Scott D et al. (2018) The Immune Landscape of Cancer. Immunity 48:812-830.e14
Wu, Bing; Zhang, Song; Guo, Zengli et al. (2018) RAS P21 Protein Activator 3 (RASA3) Specifically Promotes Pathogenic T Helper 17 Cell Generation by Repressing T-Helper-2-Cell-Biased Programs. Immunity 49:886-898.e5
Ding, Li; Bailey, Matthew H; Porta-Pardo, Eduard et al. (2018) Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. Cell 173:305-320.e10

Showing the most recent 10 out of 1525 publications